UiPath: Why The Turnaround Could Be Real This Time

UiPath remains a Buy as catalysts for its turnaround and growth story strengthen, despite a recent 44% rally. PATH trades at a 16% discount to sector median P/E and a 36% PEG discount, while delivering accelerating revenue and ARR growth. Sticky business dynamics are reinforced by rising large customer counts and robust ARR, supported by the WorkFusion acquisition. High margins, strong capital structure, and exposure to high-growth AI and RPA markets underpin the bullish thesis, though elevated short interest and margin risks persist.

Sure enough, UiPath (PATH) had a lovely 3-month run up since my previous coverage here. Whilst the benchmark has posted a 4% since my previous piece, PATH has surged by 44% and outperformed the